An FDA independent advisory panel recommended that a blood test to detect colon cancer be approved. Here's what you need to know.
The Shield blood test was able to accurately detect colorectal cancer about 83 percent of the time. It was able to detect precancerous lesions about 13 percent of the time. The prescription-only ...
May 23 (UPI) --A panel of U.S. Food and Drug Administration advisers on Thursday recommended approval for a new blood test to detect colon and rectal cancer despite concerns over the test's accuracy.
To screen for colon and rectal cancers, most people have colonoscopies, which can feel invasive and require anesthesia, or they may take an at-home stool test, which can be more convenient but ...
Credit: Guardant. Guardant Health’s Shield blood test is a qualitative in vitro diagnostic test intended to detect colorectal cancer derived alterations in cell-free DNA from blood. The Shield test is ...
To screen for colon and rectal cancers, most people have colonoscopies, which can feel invasive and require anesthesia, or they may take an at-home stool test, which can be more convenient but also ...